Sb656104a

Agomelatine 71

Selective 5HT6 agonists and antagonists (e.g., WAY466 (68), Ro-63-0563 (69), SB-171046, and GW 742457) may show therapeutic promise while a selective 5HT7 receptor antagonist (SB-656104-A (70)) has recently been reported to modulate REM sleep, part of the sleep architecture that has long been associated with depression.

Agomelatine (71) is the first melatonergic (MT1 and MT2 receptor) agonist antidepressant, with several advantages over existing antidepressant treatments.56 Besides being an effective antidepressant, agomelatine improves the often disrupted sleep patterns of depressed patients, without affecting daytime vigilance. It has no effects on sexual function, tolerability problems, or discontinuation symptoms.61

The Insomnia Battle

The Insomnia Battle

Who Else Wants To Sleep From Lights Out 'Til Sunrise Without Staring At The Ceiling For Hours Leaving You Feeling Fresh And Ready To Face A New Day You know you should be asleep. You've dedicated the last three hours in the dark to trying to get some sleep. But you're wide awake.

Get My Free Ebook


Post a comment